Strain H37Rv of Mycobacterium tuberculosis (Zopf) Lehmann and Neumann is typical of the species in growth characteristics, drug susceptibility, and biochemical activity. H37Rv is compared with the hypothetical median strain of M. tuberculosis and agrees with it in 70 of 71 characters. In comparison with other strains of tubercle bacilli, H37Rv has moderate virulence for guinea pigs and mice. This strain agrees well with Koch’s original description of the tubercle bacillus; the few differences that do exist are discussed. The well documented history of H37Rv, coupled with its world-wide distribution and long use by mycobacteriologists, makes it most appropriate as the neotype of the species M. tuberculosis. The strain may be obtained from the Trudeau Institute, Inc., Saranac Lake, N.Y. 12983, as TMC 102 or from the American Type Culture Collection, Rockville, Md. 20852, as 27294.
AbbottV. D., KilburnJ. O., HarbisonW., KubicaG. P.1968; Differential identification of mycobacteria. IV. The nitrite inhibition test. Amer. Rev. Resp. Dis. 97:931–934
CollinsF. M., MackanessG. B., MontalbineV., SmithM. M.1968; A comparison of the Steenken minimal inhibitory concentration and the Canetti proportion methods for determining levels of drug resistance in cultures of Mycobacterium tuberculosis. Amer. Rev. Resp. Dis. 98:189–200
CollinsF. M., SmithM. M.1969; A comparative study of the virulence of Mycobacterium tuberculosis measured in mice and guinea pigs. Amer. Rev. Resp. Dis. 100:631–639
Editorial Board, Judicial Commission of the International Committee on Nomenclature of Bacteria1966; International Code of Nomenclature of Bacteria. Int. J. Syst. Bacteriol. 16:459490
GordonR. E., SmithM. M.1953; Rapidly growing, acid-fast bacteria. I. Species’ descriptions of Mycobacterium phlei Lehmann and Neumann and Mycobacterium smegmatis (Trevisan) Lehmann and Neumann. J. BacterioL 66:41–48
GroverA. A., KimH. K., WiegeshausE. H., SmithD. W.1967; Host-parasite relationships in experimental airborne tuberculosis. II. Reproducible infection by means of an inoculum preserved at -70 C. J. Bacteriol. 94:832–835
HokT. T.1962; A new method for the differentiation of human tubercle bacilli from other types of mycobacteria, using nicotinamidecontaining medium (nicotinamide test). Amer. Rev. Resp. Dis. 86:94
JonesW. D.Jr., KubicaG. P.1963; The differential typing of certain rapidly growing mycobacteria based on their sensitivity to various dyes. Amer. Rev. Resp. Dis. 88:355–359
JonesW. D.Jr., AbbottV. D., VestalA. L., KubicaG. P.1966; A hitherto undescribed group of nonchromogenic mycobacteria. Amer. Rev. Resp. Dis. 94:790–795
JonesW. D.Jr., KubicaG. P.1965; The differential groupings of slowly growing mycobacteria based on their susceptibility to various dyes. Amer. Rev. Resp. Dis. 91:613–615
KestleD. G., AbbottV. D., KubicaG. P.1967; Differential identification of mycobacteria. II. Subgroups of groups II and III (Runyon) with different clinical significance. Amer. Rev. Resp. Dis. 95:1041–1052
KilburnJ. O., SilcoxV. A., KubicaG. P.1969; Differential identification of mycobacteria. V. The tellurite reduction test. Amer. Rev. Resp. Dis. 99:94–100
KochR.1882; Die Aetiologie der Tuberkulose. Berl. klin. Wchschr. 19:221 A translation from the German was prepared by Dr. and Mrs. Max Pinner to commemorate the 50th anniversary of the discovery of the tubercle bacillus; this was published in Amer. Rev. Tuberc. 25: 285–323; 1932
KubicaG. P., DyeW. E.1967 Laboratory methods for clinical and public health mycobacteriology. U. S. Pub. Health Serv. Pub. Health Monogr. no. 1547 Washington D.C.:
KubicaG. P., JonesW. D.Jr., AbbottV. D., BeamR. E., KilburnJ. O., CaterJ. C.Jr.1966; Differential identification of mycobacteria. I. Tests on catalase activity. Amer. Rev. Resp. Dis. 94:400–405
KubicaG. P., PoolG. L.1960; Studies on the catalase activity of acid-fast bacilli. I. An attempt to subgroup these organisms on the basis of their catalase activities at different temperature and pH. Amer. Rev. Resp. Dis. 81:387–391
OatwayW. H.Jr., SteenkenW.Jr.1936; The pathogenesis and fate of tubercle produced by dissociated variants of tubercle bacilli. J. Infec. Dis. 59:306–325
SteenkenW.Jr., GardnerL. U.1943; Vaccinating properties of avirulent dissociates of five different strains of tubercle bacilli. Yale J. Biol. Med. 15:393402
SteenkenW.Jr., MontalbineV., ThurstonJ. R.1959; The antituberculous activity of Kanamycin in vitro and in the experimental animal (guinea pig). Amer. Rev. Tuberc. 79:6671
SteenkenW.Jr., OatwayW. H.Jr., PetroffS. A.1934; Biological studies of the tubercle bacillus. HI. Dissociation and pathogenicity of the R. and S. variants of the human tubercle bacillus. (H3Z). J. Exp. Med. 60:515–540
StottmeierK. D., BeamR. E., KubicaG. P.1967; Determination of drug susceptibility of mycobacteria to pyrazinamide in 7H10 agar. Amer. Rev. Resp. Dis. 96:1072–1075
StottmeierK. D., KubicaG. P., WoodleyC. L.1969; Antimycobacterial activity of rifampin under in vitro and simulated in vivo conditions. Appl. Microbiol. 17:861–865
VestalA. L., KubicaG. P.1967; Differential identification of mycobacteria. HI. Use of thiacetazone, thiophen-2-carboxylic acid hydrazide, and triphenyltetrazolium chloride. Scand. J. Resp. Dis. 48:142–148
WayneL. G., DoubekJ. R.1965; Classification and identification of mycobacteria. II. Tests employing nitrate and nitrite as substrate. Amer. Rev. Resp. Dis. 91:738–745
WayneL. G., DoubekJ. R., RussellR. L.1964; Classification and identification of mycobacteria. I. Tests employing Tween 80 as a substrate. Amer. Rev. Resp. Dis. 90:588–597
WoodruffC. D., CrombieD., MedlarE., WoodleyJ. S., SteenkenW.1946; Report of the committee on evaluation of laboratory procedures. Amer. Rev. Tuberc. 54:428432